The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma
European Respiratory Journal · 2024-04 · 63 (4) · 2301397
DOI: 10.1183/13993003.01397-2023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 07.03.2024. Verfasst von Richard J Russell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK rjr22@leicester.ac.uk. Hauptthemen laut MEDLINE: Asthma. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen, AstraZeneca.
Abstract (Originalsprache)
Asthma is a disease of heterogeneous pathology, typically characterised by excessive inflammatory and bronchoconstrictor responses to the environment. The clinical expression of the disease is a consequence of the interaction between environmental factors and host factors over time, including genetic susceptibility, immune dysregulation and airway remodelling. As a critical interface between the host and the environment, the airway epithelium plays an important role in maintaining homeostasis in the face of environmental challenges. Disruption of epithelial integrity is a key factor contributing to multiple processes underlying asthma pathology. In this review, we first discuss the unmet need in asthma management and provide an overview of the structure and function of the airway epithelium. We then focus on key pathophysiological changes that occur in the airway epithelium, including epithelial barrier disruption, immune hyperreactivity, remodelling, mucus hypersecretion and mucus plugging, highlighting how these processes manifest clinically and how they might be targeted by current and novel therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK rjr22@leicester.ac.uk.
- Quebec Heart and Lung Institute, Laval University, Quebec, QC, Canada.
- Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
- Respiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark.
- Centre for Heart Lung Innovation, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
ORCID-Profile: Celeste Porsbjerg
Förderung
- Amgen
- AstraZeneca
Zitieren
APA
Russell, R. J., Boulet, L. P., Brightling, C. E., Pavord, I. D., Porsbjerg, C., Dorscheid, D., & Sverrild, A. (2024). The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma. European Respiratory Journal, 63(4), 2301397. https://doi.org/10.1183/13993003.01397-2023
Vancouver
Russell RJ, Boulet LP, Brightling CE, Pavord ID, Porsbjerg C, Dorscheid D, et al. The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma. European Respiratory Journal. 2024;63(4):2301397. doi:10.1183/13993003.01397-2023
BibTeX
@article{Russell2024,
author = {Russell, Richard J and Boulet, Louis-Philippe and Brightling, Christopher E and Pavord, Ian D and Porsbjerg, Celeste and Dorscheid, Del and Sverrild, Asger},
title = {The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma},
journal = {European Respiratory Journal},
year = {2024},
volume = {63},
number = {4},
pages = {2301397},
doi = {10.1183/13993003.01397-2023}
}
EUVIMED